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Abstract
Purpose The Ponseti method is a well-established approach 
to treating clubfoot. Potentially, both the underlying patholo-
gy and adherence to post-correction bracing can affect lower 
limb function and age of independent standing and walking. 
This cohort study investigates the age at which infants with id-
iopathic clubfoot treated using the Ponseti method achieved 
three selected developmental milestones and whether or not 
this correlated with treatment compliance.
Methods A prospectively collected database from four cen-
tres was visited. Inclusion criteria were patients with idio-
pathic clubfoot with no comorbidities or prior treatment. Age 
at attainment of independent standing, walking, nocturnal 
continence was compared across three groups: I) congeni-
tal talipes equinovarus (CTEV) children compliant with treat-
ment; II) CTEV children non-compliant with treatment; and 
III) typically-developed siblings. Minimum follow-up was five 
years.
Results In all, 130 patients (198 feet) fitted the inclusion cri-
teria: 43:87 (F:M). Standing was achieved by a mean 12.0 
months in group I (sd 2.50); 12.0 months (sd 2.0) in II and 
ten months (sd 3.0) in III. Walking was achieved by a mean 
15 months (sd 4.0) in group I, 14 months (sd 1.75) in II and 
12 months (sd 3) in III, respectively. Both the compliant and 
non-compliant CTEV children were significantly slower at 
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achieving standing and walking compared to sibling controls 
(p < 0.0001). There was no significant difference between age 
of nocturnal continence between the three groups. 
Conclusion Infants with idiopathic clubfoot treated accord-
ing to the Ponseti method achieve independent standing 
and walking approximately two months later than their 
 typically-developed siblings. The delay is not related to the 
use of the foot abduction brace.
Level of evidence: III
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Introduction
Congenital talipes equinovarus (CTEV) is a common con-
genital foot abnormality, with an incidence of approxi-
mately one in 1000 live births. The Ponseti method has 
become the benchmark approach to treating idiopathic 
clubfoot.1 This method has reduced the need for radical 
surgery2,3 due to a reported primary correction rate of 
95% or more.2
However, non-compliance with foot abduction brace 
(FAB) use post-casting has been recognized as a signifi-
cant risk factor for the recurrence of clubfoot after primary 
correction.4. FAB use poses challenges along the treat-
ment path with variable compliance rates. Factors such 
as the level of education of parents, belief in necessity of 
the brace and the level of information given and under-
standing gained about the treatment course have been 
shown to have a direct effect on compliance.1,5 In a recent 
study, non-compliance with the FAB was associated with 
parents’ perception of its effect in restricting movement.6 
Some parents fear a negative influence of the brace on the 
motor development of their child.1 Others have expressed 
concern regarding effect on nocturnal enuresis due to dif-
ficulty in the child’s ability to get out of bed independently 
at night. Nocturnal enuresis is defined as bedwetting more 
than twice per week, past the age of five years.7
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Both the underlying pathology and FAB can potentially 
have an effect on lower limb function and age of inde-
pendent standing and walking. Previous studies have 
found minimal developmental delay in gross motor skills 
in children with CTEV treated by the Ponseti method.8-10 
Compared with typically-developed children who usually 
achieve walking between 11.7 months and 12.8 months,11 
children with CTEV show a delay of only one to two 
months in walking. However, these studies are limited by 
small sample sizes and a lack of a control group. Develop-
mental milestone achievement has a range of normality 
that could be affected by genetic, geographic, cultural 
and behavioural factors.12-14 As such, no previous studies 
have compared milestones in children with clubfoot to 
their typically-developed siblings that have potentially less 
bias as controls. 
Objectives
This study aims to assess age of attainment of gross motor 
developmental milestones in children with idiopathic 
CTEV, compare this with their typically-developed sib-
lings and investigate whether there is any correlation with 
FAB use. To our knowledge this has not previously been 
reported in the literature.
Materials and methods
Design and setting
This was a multicentre cohort study. Four prospectively 
collected databases from four hospitals (St. George’s 
Hospital, London (SGH), Great Ormond Street Hospital, 
London (GOSH), Royal Surrey County Hospital, Guildford 
(RSCH) and Dana Children’s Hospital, Tel-Aviv (DCH)) were 
visited. The databases included all children who had been 
treated according to the Ponseti method for idiopathic 
CTEV since 2010. The Ponseti protocol used was compara-
ble across all sites. A retrospective cohort study was then 
performed using typically-developed siblings as controls. 
Patients
Consecutive children treated for idiopathic CTEV under 
our respective Ponseti services during the study period 
(21 December 2011 to 16 December 2013) were included 
(Appendix 1). All typically-developed siblings were included 
as controls. When data for more than one sibling was 
provided, one was selected randomly. Children with non- 
idiopathic CTEV and those who were treated primarily else-
where were excluded. Minimum follow-up was five years.
Main outcome measures
Data extracted included demographics, Pirani score at 
start of treatment, Achilles tenotomy rate and compliance 
with FAB. Data were extracted from the physiotherapy 
notes where milestones had been reported by parents and 
verified by the physiotherapist. This included independent 
standing, walking and nocturnal continence age. Noctur-
nal continence was defined as five or more dry nights per 
week. Compliance with FAB was assessed using a com-
bination of parental reporting and the physiotherapist’s 
assessment of the amount of FAB wear. This generated 
a binary value of either ‘yes’ or ‘no’ for compliance. All 
four units have worked together closely over the last five 
years and their assessment methods for FAB compliance 
are similar and repeatable.15-17 Age at which nocturnal 
continence was achieved and sibling developmental mile-
stones (standing, walking and nocturnal continence ages) 
were either collected during the physiotherapy follow-up 
appointment or from the parents via telephone call. 
Statistical analysis
Comparison of developmental milestones between hos-
pital sites was performed using analysis of variance and 
Tukey’s test for multiple comparisons. Analyzed data is pre-
sented as mean ± sd. Pearson’s correlation coefficient was 
calculated to assess correlations between developmen-
tal milestones and the Pirani score. Simple linear regres-
sions were performed in order to visualize lines of best 
fit. Comparison of developmental milestones between 
CTEV children complaint with FAB, CTEV children non- 
compliant with FAB and controls was performed using 
the  Kruskal-Wallis test and the pairwise Wilcoxon post hoc 
test for multiple comparisons. This was due to the distri-
bution of the non-compliant group. Analyzed data was 
presented as median ± interquartile range.
Statistical analyses were performed using RStudio 
1.1.463 (Boston, Massachusetts) and GraphPad Prism 
6 (San Diego, California). Significance was defined as 
p < 0.05.
This study was approved by the St. George’s University 
and Dana Children’s Hospital institutional review boards 
and National Health Service Health Research Authority 
(REC Reference: 19/HRA/0512).
Results
A total of 130 children with 198 clubfeet were included. 
In all, 130 sibling controls were included. The flowchart 
of the patient selection is presented in the supplementary 
material. Table 1 presents the demographics and treat-
ment data.
Figure 1 presents the age of achieving the selected 
developmental milestones in CTEV patients compliant 
with the FAB (Group I), non-compliant CTEV patients 
(Group II) and the typically-developed sibling controls 
(Group III).
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Standing
The median age by which standing was achieved for the 
three groups was 12.0 months (± 2.50); 12.0 months 
(± 2.0) and ten months (± 3.0), respectively (Fig. 1). Both 
the compliant and non-compliant CTEV children were sig-
nificantly slower at achieving standing, compared with 
sibling controls (p < 0.0001). 
Walking
The median age at which walking was achieved in the 
three groups was 15 months (± 4.0), 14 months (± 1.75) 
and 12 months (± 3), respectively (Fig. 1). Both the com-
pliant and non-compliant CTEV children were signifi-
cantly slower at achieving walking, compared with sibling 
controls (p < 0.0001). In all, 93% (121) of CTEV children 
Table 1 Study demographics 
Category Characteristic n (%/sd)
Hospital site St. George’s Hospital (SGH) 41
Great Ormond Street Hospital (GOSH) 21
Royal Surrey County Hospital (RSH) 16
Dana Children’s Hospital (DCH) 52
Total number 130
Sex Male 87 (66.9)
Female 43 (33.1)
Affected foot Left only 29 (22.3)
Right only 33 (25.4)
Bilateral 68 (52.3)
Total number of feet 198
Mean Pirani score at start of  
treatment
SGH 4.8 (sd 1.4)
GOSH 5.1 (sd 1.3)
RSH 4.7 (sd 1.3)
DCH 5.1 (sd 1.0)
All sites 4.9 (sd 1.3)
Achilles tenotomy Yes 114 (87.7)
No 15 (11.5)
Unknown 1 (0.8)
Compliance Yes 110 (84.6)
No 17 (13.1)
Unknown 3 (2.3)
Fig. 1 Standing, walking and nocturnal continence age in congenital talipes equinovarus (CTEV) patients 
compliant to the foot abduction brace (FAB), CTEV patients non-compliant to the FAB, compared with their 
typically developed siblings. Bars show median and upper quartile. 
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achieved walking before or at 18 months of age, regard-
less of compliance. 
Nocturnal continence
The median age at which nocturnal continence was 
achieved in the three groups was 3.0 years (± 1.5), 2.5 
years (± 1.75) and 3.0 years (± 1.0), respectively (Fig. 1). 
These differences were not significant (p = 0.151). In all, 
95% (124) of children with CTEV achieved nocturnal con-
tinence by age five years or earlier.
Comparison across sites
The developmental milestones in the study group were 
compared across each study site (Fig. 2). There was no 
significant difference in standing age between the four 
sites (p = 0.99). Children from DCH achieved walking 
a month later than children from the other three sites 
(p  =  0.011). Children from DCH achieved continence at 
night significantly earlier than children from the other 
three sites (p = 0.02). A total of 17 children (13.1%) were 
non- compliant with FAB use. Six of these children (4.6%) 
had been treated at SGH and 11 (8.5%) at DCH. Compli-
ance data was not available for three children (2.3%).
Correlation with Pirani score
Developmental milestones were correlated against Pirani 
score to assess the effect of CTEV severity on development 
(Fig. 3). If two feet were affected, the higher-scoring foot 
was selected for analysis, as we hypothesize that a more 
severely affected foot would have a greater impact on 
development. There was no correlation between the CTEV 
severity and standing, walking and nocturnal continence 
ages (Table 2).
Discussion 
Idiopathic CTEV is a common congenital foot abnormality 
with the majority of the patients achieving primary cor-
rection using the Ponseti method. However, little is known 
about its impact on attainment of developmental mile-
stones. No previous studies have compared attainment of 
developmental milestones in children with CTEV treated 
with the Ponseti method to typically-developed siblings. 
In this study, we have found a statistically significant delay 
in attainment of standing and walking in children with 
CTEV, regardless of whether they were compliant with 
the FAB, compared with their typically-developed sibling 
controls. This age of attainment appears to be delayed 
also compared with studies of otherwise healthy children, 
where the mean age range of walking reported is between 
11.7 months and 12.8 months.11 The extent of the delay in 
walking in this study is consistent with previous studies,10 
which found that the mean age of walking achieved was 
14.5 months.9 However, whilst this difference is statisti-
cally significant, it is unlikely to be clinically meaningful 
Fig. 2 Standing, walking and nocturnal continence age in congenital talipes equinovarus (CTEV) patients 
compared across all four hospital sites. Bars show mean and standard deviation (SGH, St. George’s Hospital; 
GOSH, Great Ormond Street Hospital; RSH, Royal Surrey County Hospital; DCH, Dana Children’s Hospital).
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and this delay should not cause a lasting effect on devel-
opment. The majority of children with CTEV have com-
parable motor abilities by the time they reach nine years 
of age and can participate in sports such as dancing and 
skiing without impairment.3 Moreover, many typical-
ly-developed children do not attain standing and walking 
by the mean age of the population; indeed, the control 
group within this study achieved walking by a mean age 
of 13.3 months, which is still later than the theoretical 
population mean. Arguably, it is better to look at limit 
ages, which denotes the age by which all children should 
have achieved a developmental milestone. The commonly 
accepted limit age for the attainment of walking is 18 
months.18 In all, 93% of the CTEV-affected children in this 
study achieved walking by or at 18 months. Therefore, 
whilst affected children may be slightly delayed compared 
with their non-affected siblings, they will still achieve their 
motor developmental milestones well within the age limit 
of the healthy population.9
The effect of CTEV and the Ponseti method on noctur-
nal continence was also studied. Many parents express 
concerns over whether the FAB increases the risk of noc-
turnal enuresis by hindering the child from getting out of 
bed during the night. No previous studies have assessed 
whether there is a true effect. The difference in age at 
which night-time continence was achieved between chil-
dren compliant with the FAB, non-compliant children and 
the control group was not significant. Only six children 
met the criteria for nocturnal enuresis,7 suggesting that 
most children with CTEV, whether or not compliant with 
the FAB, become continent at night well within the nor-
mal distribution of the population. Therefore, it is unlikely 
that the FAB has a significant clinical impact on the noctur-
nal diaper weaning of a child. 
We attempted to ascertain whether the delay in reach-
ing developmental milestones is a result of the Ponseti 
method or due to the underlying CTEV pathology. Garcia 
et al8 suggest that the use of casting and splinting early in 
life may impair the balance and strength of the muscles 
involved, therefore delaying motor development. Other 
studies also suggest that the presence of a clubfoot is a 
marker for a more global underlying motor dysfunction.19 
This is demonstrated by the muscular atrophy seen in the 
lower leg in clubfoot that persists even after correction. 
No correlation was found between severity of CTEV, as 
assessed by the Pirani score prior to treatment and the age 
by which the developmental milestones were reached. 
This applied for children with both unilateral and bilateral 
CTEV. This implies that the Pirani score at presentation 
has no bearing on any subsequent motor delay. This is 
Fig. 3 The association between the severity of congenital talipes equinovarus, as measured by a Pirani score, and standing, 
walking and nocturnal continence ages. Line depicts best fit. Red circles represent children with only one foot affected; blue 
circles represent children with both feet affected. 
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consistent with previous studies that have shown that the 
Pirani score at presentation does not affect treatment out-
comes.15,20
Additionally, we compared the age of attainment 
of the three developmental milestones between chil-
dren with CTEV who were compliant with the FAB with 
those who were not. We found no significant differences 
between these groups. Therefore, it is unlikely that com-
pliance with FAB had any clinical impact on develop-
mental milestones through persistent immobility. It is 
much more likely that the mild delay seen in children 
with CTEV is multi-factorial, due to a combination of 
primary pathological factors, factors secondary to treat-
ment and cultural and behavioural factors. It is important 
to acknowledge that whilst FAB use does not appear to 
affect developmental milestones at the time of primary 
correction, compliance with FAB is an important predic-
tor of relapse at a later date.4 This can have its own impact 
on developmental milestones through a recurrent foot 
deformity.
We assessed whether the attainment of milestones was 
consistent across the different study sites. Whilst there 
was no difference in standing age between the children 
from different sites, the children from DCH were slower to 
develop independent walking but faster at achieving noc-
turnal continence compared with the United Kingdom- 
based hospitals. The reason for this effect is unclear. As 
the children from DCH were from a different country than 
the other three centres it is possible that this difference 
is confounded by both genetic and environmental factors 
amongst the DCH children. In reality, the relative impact 
of these differences is minor, and may fall within the natu-
ral variation for all children. 
This study is subject to some limitations. Only 17 
(13.1%) of the children were non-compliant with the FAB 
which resulted in a skew in data. It is also possible that a 
proportion of non-compliant children were excluded as 
they did not have a sibling to compare with. The results 
of the non-parametric analysis of this question were sig-
nificant and, therefore, meaningful. The sibling develop-
mental milestone data relied on parental recall, which 
could be subject to inaccuracy. To assess for this, we con-
ducted a reliability study on 30 patients before the study 
commenced and found excellent accuracy in parents’ 
reporting of developmental milestones compared with 
documented milestones in the physiotherapy notes. Pre-
vious data also suggests that parents’ recall of their child’s 
walking age is often accurate and correlates well with true 
walking age. One study found that at three years old, there 
was greater than 70% correlation between parental recall 
and true walking ages.21 We hypothesize that attainment 
of developmental milestones may be even more signifi-
cant in families of children with CTEV, therefore, caregiv-
ers are likely to be even more vigilant in monitoring their 
child’s development.
The major strength of this paper is the ability to com-
pare children with CTEV to their typically-developed 
siblings which has not been previously reported in the 
literature. Comparison with siblings may be able to 
overcome bias due to geographic, cultural and genetic 
diversity which gives a more accurate comparison of the 
milestones achieved.12-14
Conclusion
There is a mild developmental delay in the attainment of 
motor milestones in children with CTEV treated with the 
Ponseti method. However, it is unlikely that this delay is 
clinically significant. There is no delay in the attainment 
of nocturnal continence as a result of the use of the Pon-
seti method. This allows us to reassure parents regarding 
the FAB use as part of the Ponseti treatment programme 
and to emphasize its importance for the prevention of 
relapse. 
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coefficients
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Appendix 1
Flowchart of the patient selection process.
